AAAAAA

   
Results: 1-17 |
Results: 17
IS THERE AN ASSOCIATION BETWEEN THE EFFECTS OF CLOZAPINE ON THE PRODUCTION OF REACTIVE OXYGEN METABOLITES BY BLOOD MONOCYTES AND CLINICAL OUTCOME IN NEUROLEPTIC-RESISTANT SCHIZOPHRENIA
Authors: JOFFE G NYBERG P GROSS A APPELBERG B
Citation: G. Joffe et al., IS THERE AN ASSOCIATION BETWEEN THE EFFECTS OF CLOZAPINE ON THE PRODUCTION OF REACTIVE OXYGEN METABOLITES BY BLOOD MONOCYTES AND CLINICAL OUTCOME IN NEUROLEPTIC-RESISTANT SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 172-172
IS THERE AN ASSOCIATION BETWEEN THE EFFECTS OF CLOZAPINE ON THE PRODUCTION OF REACTIVE OXYGEN METABOLITES BY BLOOD MONOCYTES AND CLINICAL OUTCOME IN NEUROLEPTIC-RESISTANT SCHIZOPHRENIA
Authors: JOFFE G NYBERG P GROSS A APPELBERG B
Citation: G. Joffe et al., IS THERE AN ASSOCIATION BETWEEN THE EFFECTS OF CLOZAPINE ON THE PRODUCTION OF REACTIVE OXYGEN METABOLITES BY BLOOD MONOCYTES AND CLINICAL OUTCOME IN NEUROLEPTIC-RESISTANT SCHIZOPHRENIA, Human psychopharmacology, 13(4), 1998, pp. 231-237
CLOZAPINE RESPONSE IN EARLY TREATMENT-RESISTANT SCHIZOPHRENIA
Authors: JOFFE G RYBAK J BURKIN M BURKIN D APPELBERG B JOFFE M GADEKE R RIMON R
Citation: G. Joffe et al., CLOZAPINE RESPONSE IN EARLY TREATMENT-RESISTANT SCHIZOPHRENIA, Nordic journal of psychiatry, 52, 1998, pp. 16-16
DO THE IN-VITRO EFFECTS OF CLOZAPINE ON THE PRODUCTION OF REACTIVE OXYGEN METABOLITES BY BLOOD MONOCYTES PREDICT THE CLINICAL-RESPONSE TO CLOZAPINE IN NEUROLEPTIC-RESISTANT SCHIZOPHRENIA
Authors: JOFFE G NYBERG P GROSS A APPELBERG B
Citation: G. Joffe et al., DO THE IN-VITRO EFFECTS OF CLOZAPINE ON THE PRODUCTION OF REACTIVE OXYGEN METABOLITES BY BLOOD MONOCYTES PREDICT THE CLINICAL-RESPONSE TO CLOZAPINE IN NEUROLEPTIC-RESISTANT SCHIZOPHRENIA, Nordic journal of psychiatry, 52(2), 1998, pp. 114-115
NO DIFFERENCES IN PHOSPHOLIPASE-A(2) ACTIVITY BETWEEN ACUTE PSYCHIATRIC-PATIENTS AND CONTROLS
Authors: KATILA H APPELBERG B RIMON R
Citation: H. Katila et al., NO DIFFERENCES IN PHOSPHOLIPASE-A(2) ACTIVITY BETWEEN ACUTE PSYCHIATRIC-PATIENTS AND CONTROLS, Schizophrenia research, 26(2-3), 1997, pp. 103-105
CLOZAPINE RESPONSE IN EARLY TREATMENT-RESISTANT SCHIZOPHRENIA
Authors: JOFFE G RYBAK J BURKIN M BURKIN D APPELBERG B JOFFE M GADEKE R RIMON R
Citation: G. Joffe et al., CLOZAPINE RESPONSE IN EARLY TREATMENT-RESISTANT SCHIZOPHRENIA, Nordic journal of psychiatry, 51(2), 1997, pp. 99-99
PLASMA INTERLEUKIN-1-BETA AND SLEEP ARCHITECTURE IN SCHIZOPHRENIA ANDOTHER NONAFFECTIVE PSYCHOSES
Authors: APPELBERG B KATILA H RIMON R
Citation: B. Appelberg et al., PLASMA INTERLEUKIN-1-BETA AND SLEEP ARCHITECTURE IN SCHIZOPHRENIA ANDOTHER NONAFFECTIVE PSYCHOSES, Psychosomatic medicine, 59(5), 1997, pp. 529-532
PHOSPHOLIPASE-A(2) ACTIVITY IN PSYCHOTIC-PATIENTS
Authors: KATILA H APPELBERG B RIMON R
Citation: H. Katila et al., PHOSPHOLIPASE-A(2) ACTIVITY IN PSYCHOTIC-PATIENTS, Schizophrenia research, 18(2-3), 1996, p.
PLASMA INTERLEUKIN-1-BETA AND SLEEP ARCHITECTURE IN SCHIZOPHRENIA ANDOTHER NONAFFECTIVE PSYCHOSES
Authors: APPELBERG B KATILA H RIMON R
Citation: B. Appelberg et al., PLASMA INTERLEUKIN-1-BETA AND SLEEP ARCHITECTURE IN SCHIZOPHRENIA ANDOTHER NONAFFECTIVE PSYCHOSES, Schizophrenia research, 18(2-3), 1996, p.
ATYPICAL LYMPHOCYTES IN SCHIZOPHRENIA
Authors: LAHDELMA RL KATILA H HIRATAHIBI M ANDERSSON L APPELBERG B RIMON R
Citation: Rl. Lahdelma et al., ATYPICAL LYMPHOCYTES IN SCHIZOPHRENIA, European psychiatry, 10(2), 1995, pp. 92-96
PLASMA-LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-6 IN SCHIZOPHRENIA, OTHER PSYCHOSES, AND AFFECTIVE-DISORDERS
Authors: KATILA H APPELBERG B HURME M RIMON R
Citation: H. Katila et al., PLASMA-LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-6 IN SCHIZOPHRENIA, OTHER PSYCHOSES, AND AFFECTIVE-DISORDERS, Schizophrenia research, 12(1), 1994, pp. 29-34
PLASMA AND CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA INTERLEUKIN-6 IN HOSPITALIZED SCHIZOPHRENIC-PATIENTS
Authors: KATILA H HURME M WAHLBECK K APPELBERG B RIMON R
Citation: H. Katila et al., PLASMA AND CEREBROSPINAL-FLUID INTERLEUKIN-1-BETA INTERLEUKIN-6 IN HOSPITALIZED SCHIZOPHRENIC-PATIENTS, Neuropsychobiology, 30(1), 1994, pp. 20-23
THE EFFECT OF FLUOXETINE ON SLEEP - A LONGITUDINAL, DOUBLE-BLIND POLYSOMNOGRAPHIC STUDY OF HEALTHY-VOLUNTEERS
Authors: VASAR V APPELBERG B RIMON R SELVARATNAM J
Citation: V. Vasar et al., THE EFFECT OF FLUOXETINE ON SLEEP - A LONGITUDINAL, DOUBLE-BLIND POLYSOMNOGRAPHIC STUDY OF HEALTHY-VOLUNTEERS, International clinical psychopharmacology, 9(3), 1994, pp. 203-206
ANTIDEPRESSANT EFFICACY AND QUALITY-OF-LIFE IN DEPRESSION - A DOUBLE-BLIND-STUDY WITH MOCLOBEMIDE AND FLUOXETINE
Authors: LONNQVIST J SINTONEN H SYVALAHTI E APPELBERG B KOSKINEN T MANNIKKO T MEHTONEN OP NAARALA M SIHVO S AUVINEN J PITKANEN H
Citation: J. Lonnqvist et al., ANTIDEPRESSANT EFFICACY AND QUALITY-OF-LIFE IN DEPRESSION - A DOUBLE-BLIND-STUDY WITH MOCLOBEMIDE AND FLUOXETINE, Acta psychiatrica Scandinavica, 89(6), 1994, pp. 363-369
EFFECTS OF LIGHT TREATMENT ON SLEEP STRUCTURE IN SEASONAL AFFECTIVE-DISORDER
Authors: PARTONEN T APPELBERG B PARTINEN M
Citation: T. Partonen et al., EFFECTS OF LIGHT TREATMENT ON SLEEP STRUCTURE IN SEASONAL AFFECTIVE-DISORDER, European archives of psychiatry and clinical neuroscience, 242(5), 1993, pp. 310-313
INTERFERON-A AS ADJUVANT TREATMENT IN CHRONIC-SCHIZOPHRENIA
Authors: KATILA H CANTELL C APPELBERG B WAHLBECK K NAUKKARINEN H RIMON R
Citation: H. Katila et al., INTERFERON-A AS ADJUVANT TREATMENT IN CHRONIC-SCHIZOPHRENIA, Neuropsychobiology, 28(4), 1993, pp. 192-196
IS THERE A SEASONAL-VARIATION IN THE INTERFERON-PRODUCING CAPACITY OFHEALTHY-SUBJECTS
Authors: KATILA H CANTELL K APPELBERG B RIMON R
Citation: H. Katila et al., IS THERE A SEASONAL-VARIATION IN THE INTERFERON-PRODUCING CAPACITY OFHEALTHY-SUBJECTS, Journal of interferon research, 13(3), 1993, pp. 233-234
Risultati: 1-17 |